Trials / Completed
CompletedNCT04603599
Relationship of Endometrial Cancer and Serum Soluble L1CAM Level
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 146 (actual)
- Sponsor
- Kocaeli University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effect of serum soluble L1CAM (sL1CAM) on the diagnosis and prognosis of endometrial cancer. This prospective randomized controlled trial will be conducted in patients who have undergone endometrial biopsy and whose pathology results are reported as benign endometrial changes, endometrial hyperplasia, or endometrial cancer. The sL1CAM level between groups will be compared. The relationship between prognostic factors and serum sL1CAM will be evaluated in patients with endometrial cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | serum soluble L1CAM (sL1CAM) | blood sample |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2020-10-27
- Last updated
- 2020-11-02
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04603599. Inclusion in this directory is not an endorsement.